TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Pharmarise Holdings Corp. ( (JP:2796) ).
Pharmarise Holdings Corporation reported its consolidated financial results for the fiscal year ending May 31, 2025, showing a significant increase in net sales by 16.6% to 63,508 million yen. However, the company faced a decline in operating profit and ordinary profit, with a net loss attributable to owners of the parent company amounting to 367 million yen. The company’s financial position saw a decrease in net assets and equity ratio, while cash flows from operating activities decreased. The company also announced a reduction in dividends per share from 20 yen to 14 yen. Despite these challenges, Pharmarise Holdings forecasts a positive outlook for the next fiscal year, with expected growth in net sales and profits.
More about Pharmarise Holdings Corp.
Pharmarise Holdings Corporation is a company listed on the Tokyo Stock Exchange, primarily involved in the pharmaceutical industry. The company focuses on providing healthcare products and services, with a market focus on the Japanese healthcare sector.
Average Trading Volume: 29,773
Technical Sentiment Signal: Sell
Current Market Cap: Yen5.86B
See more data about 2796 stock on TipRanks’ Stock Analysis page.